Insilico Medicine vs Yellow.ai
Relationship
Assembled from the recorded fields for this pair, not hand-checked. The comparison below is read from each company’s own profile.
Aligned comparison
Capability overlap
Shared · 4
Not verified for Yellow.ai · 4
Recorded for Insilico Medicine. Yellow.ai’s product records say nothing either way — a missing record is not a missing capability.
Not verified for Insilico Medicine · 3
Recorded for Yellow.ai. Insilico Medicine’s product records say nothing either way — a missing record is not a missing capability.
Products, side by side
Algorithmic pairing — assembled from recorded fields, not hand-checked
Insilico Medicine
Application
AI research writing assistant that drafts structured, cited papers, reviews, grant proposals and abstracts against biomedical databases such as PubMed and bioRxiv.
Multimodal AI platform that forecasts the probability of success of individual clinical trials and scores alternative trial designs before implementation.
Yellow.ai
Application
AI suggestions and workflows for human support teams handling live conversations.
Conversation analytics over AI agent interactions, with visibility into customer behaviour and agent performance.
Retrieves enterprise knowledge for conversational agents using agentic RAG.
Uses LLMs to understand unstructured support emails, infer intent and urgency, and trigger automated resolution or escalation workflows.
No counterpart
Insilico Medicine sells these in a stack layer with no product recorded for Yellow.ai yet — nothing on the other side to compare them against.
Platform
AI platform for de novo design and multi-property optimization of peptides, nanobodies and antibodies against specified targets and epitopes.
Generative small-molecule design platform combining de novo generation with physics-based methods, retrosynthesis, ADMET profiling and custom model training.
Foundation-model training and benchmarking platform that fine-tunes a customer's own LLM on Insilico's proprietary pharma reasoning datasets and validates results in its automation lab.
AI platform for therapeutic target identification, biomarker discovery, indication prioritization and drug repurposing over a multi-omics knowledge base.
End-to-end generative-AI platform spanning target discovery, molecular design and clinical-trial risk assessment for pharmaceutical research.
Hardware
On-premise AI appliance running PandaOmics target and biomarker discovery locally with no external data transmission, sold in Server and Desktop editions.
Yellow.ai sells these in a stack layer with no product recorded for Insilico Medicine yet — nothing on the other side to compare them against.
AI agent
Enterprise voice AI platform running voice agents with cloned, human-sounding voices.
Agent platform
Customer- and employee-facing agents built without code: an agent builder across channels, a knowledge base the company calls agentic RAG, a copilot for previewing and debugging what an agent did, automated testing before release, and Nexus Vox for voice.
Developer tool
Generates and executes quality tests for AI agents built on the Yellow.ai platform.